The clinical phenotype of Hb Tak often includes erythrocytosis in patients with compound heterozygous Hb Tak with β-thalassemia, homozygous Hb Tak, and Hb Tak with δβ0-thalassemia10–12. This evidence concerns the gene GSTM1 and thalassemia.